Literature DB >> 8643525

Expansion of polyglutamine repeat in huntingtin leads to abnormal protein interactions involving calmodulin.

J Bao1, A H Sharp, M V Wagster, M Becher, G Schilling, C A Ross, V L Dawson, T M Dawson.   

Abstract

Huntington's disease (HD) is an inherited neurodegenerative disorder associated with expansion of a CAG repeat in the IT15 gene. The IT15 gene is translated to a protein product termed huntingtin that contains a polyglutamine (polyGln) tract. Recent investigations indicate that the cause of HD is expansion of the polyGln tract. However, the function of huntingtin and how the expanded polyGln tract causes HD is not known. We investigate potential protein-protein interactions of huntingtin using affinity resins. Huntingtin from brain extracts is retained on calmodulin(CAM)-Sepharose in a calcium-dependent fashion. We purify rat huntingtin to apparent homogeneity using a combination of DEAE-cellulose column chromatography, ammonium sulfate precipitation, and preparative SDS/PAGE. Purified rat huntingtin does not interact with CAM directly as revealed by 125I-CAM overlay. Huntingtin forms a large CAM-containing complex of over 1,000 kDa in the presence of calcium, which partially disassociates in the absence of calcium. Furthermore, an increased amount of mutant huntingtin from HD patient brains is retained on CAM-Sepharose compared to normal huntingtin from control patient brains, and the mutant allele is preferentially retained on CAM-Sepharose in the absence of calcium. These results suggest that huntingtin interacts with other proteins including CAM and that the expansion of polyGln alters this interaction.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8643525      PMCID: PMC39402          DOI: 10.1073/pnas.93.10.5037

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  25 in total

1.  Calmodulin binding by calcineurin. Ligand-induced renaturation of protein immobilized on nitrocellulose.

Authors:  M J Hubbard; C B Klee
Journal:  J Biol Chem       Date:  1987-11-05       Impact factor: 5.157

2.  Identification of calmodulin-binding proteins.

Authors:  M L Billingsley; J W Polli; K R Pennypacker; R L Kincaid
Journal:  Methods Enzymol       Date:  1990       Impact factor: 1.600

Review 3.  Genes with triplet repeats: candidate mediators of neuropsychiatric disorders.

Authors:  C A Ross; M G McInnis; R L Margolis; S H Li
Journal:  Trends Neurosci       Date:  1993-07       Impact factor: 13.837

Review 4.  When more is less: pathogenesis of glutamine repeat neurodegenerative diseases.

Authors:  C A Ross
Journal:  Neuron       Date:  1995-09       Impact factor: 17.173

Review 5.  Huntington's disease. Pathogenesis and management.

Authors:  J B Martin; J F Gusella
Journal:  N Engl J Med       Date:  1986-11-13       Impact factor: 91.245

6.  Normal and expanded Huntington's disease gene alleles produce distinguishable proteins due to translation across the CAG repeat.

Authors:  F Persichetti; C M Ambrose; P Ge; S M McNeil; J Srinidhi; M A Anderson; B Jenkins; G T Barnes; M P Duyao; L Kanaley
Journal:  Mol Med       Date:  1995-05       Impact factor: 6.354

7.  Calmodulin and calmodulin-binding proteins in hair bundles.

Authors:  R G Walker; A J Hudspeth; P G Gillespie
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-01       Impact factor: 11.205

8.  Expression of the Huntington's disease (IT15) protein product in HD patients.

Authors:  G Schilling; A H Sharp; S J Loev; M V Wagster; S H Li; O C Stine; C A Ross
Journal:  Hum Mol Genet       Date:  1995-08       Impact factor: 6.150

9.  Huntington's disease gene (IT15) is widely expressed in human and rat tissues.

Authors:  S H Li; G Schilling; W S Young; X J Li; R L Margolis; O C Stine; M V Wagster; M H Abbott; M L Franz; N G Ranen
Journal:  Neuron       Date:  1993-11       Impact factor: 17.173

10.  Identification and localization of huntingtin in brain and human lymphoblastoid cell lines with anti-fusion protein antibodies.

Authors:  C A Gutekunst; A I Levey; C J Heilman; W L Whaley; H Yi; N R Nash; H D Rees; J J Madden; S M Hersch
Journal:  Proc Natl Acad Sci U S A       Date:  1995-09-12       Impact factor: 11.205

View more
  35 in total

1.  Transgenic mice expressing mutated full-length HD cDNA: a paradigm for locomotor changes and selective neuronal loss in Huntington's disease.

Authors:  P H Reddy; V Charles; M Williams; G Miller; W O Whetsell; D A Tagle
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1999-06-29       Impact factor: 6.237

2.  Modeling Huntington's disease in cells, flies, and mice.

Authors:  S Sipione; E Cattaneo
Journal:  Mol Neurobiol       Date:  2001-02       Impact factor: 5.590

Review 3.  Imaging in cell-based therapy for neurodegenerative diseases.

Authors:  Deniz Kirik; Nathalie Breysse; Tomas Björklund; Laurent Besret; Philippe Hantraye
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-12       Impact factor: 9.236

4.  Complex microsatellite dynamics in the myostatin gene within ruminants.

Authors:  Asa Tellgren-Roth; Grigory Kolesov; Ana M Sifuentes-Rincón; David A Liberles
Journal:  J Mol Evol       Date:  2008-03-05       Impact factor: 2.395

5.  Striatal expression of a calmodulin fragment improved motor function, weight loss, and neuropathology in the R6/2 mouse model of Huntington's disease.

Authors:  Ying Dai; Nichole L Dudek; Qian Li; Stephen C Fowler; Nancy A Muma
Journal:  J Neurosci       Date:  2009-09-16       Impact factor: 6.167

6.  The mGluR5 positive allosteric modulator VU0409551 improves synaptic plasticity and memory of a mouse model of Huntington's disease.

Authors:  Juliana G Doria; Jessica M de Souza; Flavia R Silva; Isabella G Olmo; Toniana G Carvalho; Juliana Alves-Silva; Talita H Ferreira-Vieira; Jessica T Santos; Claudymara Q S Xavier; Nathalia C Silva; Esther M A Maciel; Peter Jeffrey Conn; Fabiola M Ribeiro
Journal:  J Neurochem       Date:  2018-09-11       Impact factor: 5.372

7.  Native mutant huntingtin in human brain: evidence for prevalence of full-length monomer.

Authors:  Ellen Sapp; Antonio Valencia; Xueyi Li; Neil Aronin; Kimberly B Kegel; Jean-Paul Vonsattel; Anne B Young; Nancy Wexler; Marian DiFiglia
Journal:  J Biol Chem       Date:  2012-02-27       Impact factor: 5.157

Review 8.  Neuronal Ca(2+) dyshomeostasis in Huntington disease.

Authors:  Marta Giacomello; Juan C Oliveros; Jose R Naranjo; Ernesto Carafoli
Journal:  Prion       Date:  2013-01-01       Impact factor: 3.931

9.  Progressive synaptic pathology of motor cortical neurons in a BAC transgenic mouse model of Huntington's disease.

Authors:  J Spampanato; X Gu; X W Yang; I Mody
Journal:  Neuroscience       Date:  2008-09-18       Impact factor: 3.590

10.  Neuroprotective effects of calmodulin peptide 76-121aa: disruption of calmodulin binding to mutant huntingtin.

Authors:  Nichole L Dudek; Ying Dai; Nancy A Muma
Journal:  Brain Pathol       Date:  2009-03-10       Impact factor: 6.508

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.